Quantcast
Channel: EurekAlert! - Breaking News
Viewing all articles
Browse latest Browse all 3915

Report on remission in patients with MS 3 years after stem cell transplant

$
0
0
Three years after a small number of patients with multiple sclerosis (MS) were treated with high-dose immunosuppressive therapy (HDIT) and then transplanted with their own hematopoietic stem cells, most of the patients sustained remission of active relapsing-remitting MS (RRMS) and had improvements in neurological function, according to a study published online by JAMA Neurology.

Viewing all articles
Browse latest Browse all 3915

Trending Articles